Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Envision Healthcare Corporation (“Envision” or the “Company”) (NYSE: EVHC) concerning possible violations of federal securities laws.

To get more information about this investigation, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or by email at brian@lundinlawpc.com.

On July 24, 2017, The New York Times reported that physicians associated with Envision’s subsidiary, EmCare Holdings Inc., were disproportionately likely to engage in practices such as surprise billing in which patients who go to in-network hospitals are treated by out-of-network doctors, who then bill them at higher rates. When this information reached the public, shares of Envision declined in value.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.